Evaxion A (EVAX) Common Equity (2019 - 2026)
Evaxion A (EVAX) posted Common Equity of $13.2 million for Q1 2026, down 22.49% on a QoQ basis from $17.0 million in Q4 2025, and up 27.69% year-over-year from $10.3 million in Q1 2025.
Evaxion A (EVAX) Common Equity (2019 - 2026) Analysis & Trends
Evaxion A's Common Equity history runs 8 years deep, the most recent figure standing at $13.2 million for Q1 2026.
- Quarterly Common Equity rose 27.69% year-over-year to $13.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.2 million (up 27.69% YoY) and the FY2025 annual result came in at $17.0 million, up 1131.42% from the prior year.
- Common Equity was $13.2 million for Q1 2026 at Evaxion A, down from $17.0 million in the prior quarter.
- Across five years, Common Equity topped out at $2.6 billion in Q1 2024 and bottomed at -$4.7 million in Q4 2023.
- A 5-year average of $171.1 million and a median of $9.3 million in 2022 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2023 — Common Equity plunged 156.96% — and 2024, when it surged 39504.56%.
- Evaxion A's Common Equity stood at $8.3 million in 2022, then slumped by 156.96% to -$4.7 million in 2023, then surged by 65.07% to -$1.7 million in 2024, then jumped by 1131.42% to $17.0 million in 2025, then decreased by 22.49% to $13.2 million in 2026.
- Business Quant data shows EVAX's Common Equity at $13.2 million in Q1 2026, $17.0 million in Q4 2025, and $16.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 251.12 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -98.34 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 14.38 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 4.76 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 19.36 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 31.42 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 795.79 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.50 Bn |
| 10 | Evaxion A | 1.23 Bn | 1.23 Bn | - | 13.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.21 Mn |
| Dec 31, 2025 | 17.04 Mn |
| Sep 30, 2025 | 16.60 Mn |
| Jun 30, 2025 | 6.23 Mn |
| Mar 31, 2025 | 10.34 Mn |
| Dec 31, 2024 | -1.65 Mn |
| Jun 30, 2024 | 1.25 Mn |
| Mar 31, 2024 | 2.60 Bn |
| Dec 31, 2023 | -4.73 Mn |
| Sep 30, 2023 | -2.73 Mn |
| Jun 30, 2023 | 2.54 Mn |
| Mar 31, 2023 | 6.58 Mn |
| Dec 31, 2022 | 8.30 Mn |
| Sep 30, 2022 | 13.55 Mn |
| Jun 30, 2022 | 20.15 Mn |
| Mar 31, 2022 | 26.39 Mn |
| Dec 31, 2021 | 32.44 Mn |
| Sep 30, 2021 | 16.65 Mn |
| Jun 30, 2021 | 21.83 Mn |
| Mar 31, 2021 | 27.80 Mn |